BLT 0.00% 2.6¢ benitec biopharma limited

Benitec trading volume, page-87

  1. 1,403 Posts.
    lightbulb Created with Sketch. 96
    OPMD and HBV seems clearly where all the focus and strength lies now
    Surprisingly, both have shown impressive pre-clinical success, due to HBV patents improvements made over many years 2015'16 and 18
    OPMD due to its new "silence and replace technology and the teams vast experience.
    Both of course with unmet treatments available

 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.